Related content

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

By Wu Kai-Da   Zhou Li   Burtrum Douglas   Ludwig Dale   Moore Malcolm  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 343-357

Springer Publishing Company

Access to resources Recommend Favorite

A unique MUC1-2-VNTR DNA vaccine suppresses tumor growth and prolongs survival in a murine multiple myeloma model

By                        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1815-1822

Spandidos Publications

Access to resources Recommend Favorite

Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: Efficient suppression of growth of multiple myeloma in a murine model

By                

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1035-1040

Spandidos Publications

Access to resources Recommend Favorite

Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2411-2420

Spandidos Publications

Access to resources Recommend Favorite

MEDI3617, a human anti-Angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models

By                              

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1321-1330

Spandidos Publications

Access to resources Recommend Favorite